Literature DB >> 10565955

Molecular epidemiology of a cluster of cases due to Klebsiella pneumoniae producing SHV-5 extended-spectrum beta-lactamase in the premature intensive care unit of a Hungarian hospital.

D Szabó1, Z Filetóth, J Szentandrássy, M Némedi, E Tóth, C Jeney, G Kispál, F Rozgonyi.   

Abstract

Fifteen nosocomial cases of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae occurred among 132 neonates in a premature intensive care unit in Hungary in June through November 1998. Fourteen strains were indistinguishable by molecular biological typing and harbored the same single conjugative extended-spectrum beta-lactamase-encoding plasmid that was spontaneously found in a Serratia marcescens strain in the same patient.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10565955      PMCID： PMC85914     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

1.  Multiresistant Klebsiella pneumoniae in a neonatal nursery: the importance of maintenance of infection control policies and procedures in the prevention of outbreaks.

Authors:  Y M Coovadia; A P Johnson; R H Bhana; G R Hutchinson; R C George; I E Hafferjee
Journal:  J Hosp Infect       Date:  1992-11       Impact factor: 3.926

2.  Klebsiellae and neonates.

Authors:  C A Hart
Journal:  J Hosp Infect       Date:  1993-02       Impact factor: 3.926

3.  The use of analytical isoelectric focusing for detection and identification of beta-lactamases.

Authors:  A Mathew; A M Harris; M J Marshall; G W Ross
Journal:  J Gen Microbiol       Date:  1975-05

4.  Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens.

Authors:  H Knothe; P Shah; V Krcmery; M Antal; S Mitsuhashi
Journal:  Infection       Date:  1983 Nov-Dec       Impact factor: 3.553

5.  Molecular epidemiology of an SHV-5 extended-spectrum beta-lactamase in enterobacteriaceae isolated from infants in a neonatal intensive care unit.

Authors:  R A Venezia; F J Scarano; K E Preston; L M Steele; T P Root; R Limberger; W Archinal; M A Kacica
Journal:  Clin Infect Dis       Date:  1995-10       Impact factor: 9.079

6.  Spread of Klebsiella pneumoniae producing SHV-5 beta-lactamase among hospitalized patients.

Authors:  A Bauernfeind; E Rosenthal; E Eberlein; M Holley; S Schweighart
Journal:  Infection       Date:  1993 Jan-Feb       Impact factor: 3.553

7.  Investigation of the presence of different broad-spectrum beta-lactamases among clinical isolates of Enterobacteriacae.

Authors:  E Nagy; Z Pragai; Z Kóczián; E Hajdú; E Fodor
Journal:  Acta Microbiol Immunol Hung       Date:  1998       Impact factor: 2.048

8.  Molecular epidemiology of ceftazidime resistant Enterobacteriaceae from patients on a paediatric oncology ward.

Authors:  L C Hibbert-Rogers; J Heritage; D M Gascoyne-Binzi; P M Hawkey; N Todd; I J Lewis; C Bailey
Journal:  J Antimicrob Chemother       Date:  1995-07       Impact factor: 5.790

9.  Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins.

Authors:  K S Meyer; C Urban; J A Eagan; B J Berger; J J Rahal
Journal:  Ann Intern Med       Date:  1993-09-01       Impact factor: 25.391

10.  Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients.

Authors:  L Naumovski; J P Quinn; D Miyashiro; M Patel; K Bush; S B Singer; D Graves; T Palzkill; A M Arvin
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191
View more
  12 in total

1.  In vitro and in vivo activities of amikacin, cefepime, amikacin plus cefepime, and imipenem against an SHV-5 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain.

Authors:  D Szabó; A Máthé; Z Filetóth; P Anderlik; L Rókusz; F Rozgonyi
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

2.  Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit in the high-prevalence area of Athens, Greece.

Authors:  E Lebessi; H Dellagrammaticas; P T Tassios; L S Tzouvelekis; S Ioannidou; M Foustoukou; N J Legakis
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

Review 3.  Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.

Authors:  P A Bradford
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

4.  Occurrence and regional distribution of SHV-type extended-spectrum beta-lactamases in Hungary.

Authors:  A Tóth; M Gacs; K Márialigeti; G Cech; M Füzi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-04       Impact factor: 3.267

5.  Outbreak of infection with a multiresistant Klebsiella pneumoniae strain associated with contaminated roll boards in operating rooms.

Authors:  Annemarie van 't Veen; Anneke van der Zee; Jolande Nelson; Ben Speelberg; Jan A J W Kluytmans; Anton G M Buiting
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

Review 6.  Extended-spectrum beta-lactamases: a clinical update.

Authors:  David L Paterson; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

7.  Cefepime MIC as a predictor of the extended-spectrum beta-lactamase type in Klebsiella pneumoniae, Taiwan.

Authors:  Wen Liang Yu; Michael A Pfaller; Patricia L Winokur; Ronald N Jones
Journal:  Emerg Infect Dis       Date:  2002-05       Impact factor: 6.883

8.  Extended-spectrum beta-lactamase-producing Klebsiella spp. in a neonatal intensive care unit: risk factors for the infection and the dynamics of the molecular epidemiology.

Authors:  K Kristóf; D Szabó; J W Marsh; V Cser; L Janik; F Rozgonyi; A Nobilis; K Nagy; D L Paterson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-08       Impact factor: 3.267

9.  Reducing ventilator-associated pneumonia in neonatal intensive care unit using "VAP prevention Bundle": a cohort study.

Authors:  Seham F A Azab; Hanan S Sherbiny; Safaa H Saleh; Wafaa F Elsaeed; Mona M Elshafiey; Ahmed G Siam; Mohamed A Arafa; Ashgan A Alghobashy; Eman A Bendary; Maha A A Basset; Sanaa M Ismail; Nagwa E Akeel; Nahla A Elsamad; Wesam A Mokhtar; Tarek Gheith
Journal:  BMC Infect Dis       Date:  2015-08-06       Impact factor: 3.090

10.  Evaluation of Ertapenem use with impact assessment on extended-spectrum beta-lactamases (ESBL) production and gram-negative resistance in Singapore General Hospital (SGH).

Authors:  Cheryl Li-Ling Lim; Winnie Lee; Amanda Ling-Chiu Lee; Lisa Ting-Ting Liew; Szu Chin Nah; Choon Nam Wan; Maciej Piotr Chlebicki; Andrea Lay-Hoon Kwa
Journal:  BMC Infect Dis       Date:  2013-11-06       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.